Literature DB >> 12130694

Nicotinic receptor M3 transmembrane domain: position 8' contributes to channel gating.

María José De Rosa1, Diego Rayes, Guillermo Spitzmaul, Cecilia Bouzat.   

Abstract

The nicotinic acetylcholine receptor (nAChR) is a pentamer of homologous subunits with composition alpha(2)(beta)(epsilon)(delta) in adult muscle. Each subunit contains four transmembrane domains (M1-M4). Position 8' of the M3 domain is phenylalanine in all heteromeric alpha subunits, whereas it is a hydrophobic nonaromatic residue in non-alpha subunits. Given this peculiar conservation pattern, we studied its contribution to muscle nAChR activation by combining mutagenesis with single-channel kinetic analysis. Construction of nAChRs carrying different numbers of phenylalanine residues at 8' reveals that the mean open time decreases as a function of the number of phenylalanine residues. Thus, all subunits contribute through this position independently and additively to the channel closing rate. The impairment of channel opening increases when the number of phenylalanine residues at 8' increases from two (wild-type nAChR) to five. The gating equilibrium constant of the latter mutant nAChR is 13-fold lower than that of the wild-type nAChR. The replacement of (alpha)F8', (beta)L8', (delta)L8', and (epsilon)V8' by a series of hydrophobic amino acids reveals that the structural bases of the observed kinetic effects are nonequivalent among subunits. In the alpha subunit, hydrophobic amino acids at 8' lead to prolonged channel lifetimes, whereas they lead either to normal kinetics (delta and epsilon subunits) or impaired channel gating (beta subunit) in the non-alpha subunits. The overall results indicate that 8' positions of the M3 domains of all subunits contribute to channel gating.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130694     DOI: 10.1124/mol.62.2.406

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Role of pairwise interactions between M1 and M2 domains of the nicotinic receptor in channel gating.

Authors:  Jeremías Corradi; Guillermo Spitzmaul; María José De Rosa; Marcelo Costabel; Cecilia Bouzat
Journal:  Biophys J       Date:  2006-10-06       Impact factor: 4.033

2.  Conformational dynamics of the alphaM3 transmembrane helix during acetylcholine receptor channel gating.

Authors:  David J Cadugan; Anthony Auerbach
Journal:  Biophys J       Date:  2007-05-18       Impact factor: 4.033

3.  Design and control of acetylcholine receptor conformational change.

Authors:  Snehal V Jadey; Prasad Purohit; Iva Bruhova; Timothy M Gregg; Anthony Auerbach
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-01       Impact factor: 11.205

4.  Role of the Cys Loop and Transmembrane Domain in the Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors.

Authors:  Constanza Alcaino; Maria Musgaard; Teresa Minguez; Simone Mazzaferro; Manuel Faundez; Patricio Iturriaga-Vasquez; Philip C Biggin; Isabel Bermudez
Journal:  J Biol Chem       Date:  2016-11-18       Impact factor: 5.157

5.  Fourier transform coupled tryptophan scanning mutagenesis identifies a bending point on the lipid-exposed δM3 transmembrane domain of the Torpedo californica nicotinic acetylcholine receptor.

Authors:  Daniel Caballero-Rivera; Omar A Cruz-Nieves; Jessica Oyola-Cintrón; David A Torres-Núñez; Jose D Otero-Cruz; José A Lasalde-Dominicci
Journal:  Channels (Austin)       Date:  2011-07-01       Impact factor: 2.581

6.  A conserved cysteine residue in the third transmembrane domain is essential for homomeric 5-HT3 receptor function.

Authors:  Dai-Fei Wu; Nidaa A Othman; Douglas Sharp; Arjun Mahendra; Tarek Z Deeb; Tim G Hales
Journal:  J Physiol       Date:  2009-11-23       Impact factor: 5.182

7.  Agonist and blocking actions of choline and tetramethylammonium on human muscle acetylcholine receptors.

Authors:  Remigijus Lape; Paraskevi Krashia; David Colquhoun; Lucia G Sivilotti
Journal:  J Physiol       Date:  2009-09-14       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.